Multiplex loss of heterozygosity analysis by using single or very few cells

Journal of Molecular Diagnostics

Volumn 4, Issue 3, 2002, Pages 172-177

  Cui, Xiangfeng ^a   Feiner, Helen ^b,d   Li, Honghua ^a,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; PRIMER DNA;

ARTICLE; BREAST TUMOR; CANCER TISSUE; CELL TYPE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GENE AMPLIFICATION; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; POLYMERASE CHAIN REACTION; PROCESS OPTIMIZATION; RELIABILITY; TISSUE CULTURE; TISSUE SECTION; TUMOR SUPPRESSOR GENE; CELL LINE; GENETIC MARKER; GENOTYPE; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENETIC MARKERS; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION;

EID: 0036667668     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60699-X     Document Type: Article

References (23)

1. Mutation and cancer: Statistical study of retinoblastoma
2. Gγ-globin and parathyroid hormone loci by using the polymerase chain reaction and allele-specific oligomers
3. Multiplex genotype determination at a large number of gene loci
4. Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22
5. Primary mammary small-cell carcinoma: A molecular analysis of two cases
6. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: Correlation with proliferative activity, ploidy, and hormonal status of the tumors
7. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions
8. Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis
9. Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: Correlation to clinicopathological variables
10. The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOH in multiple cancers
11. Identification of a YAC from 16q24 carrying a senescence gene for breast cancer cells
12. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases
13. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region
14. The Fanconi Anaemia/Breast Cancer Consortium: Positional cloning of the Fanconi anaemia group A gene
15. Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3
16. Genetic studies of 457 breast cancers: Clinicopathologic parameters compared with genetic alterations
17. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespective of differences in phenotype and extent of spread
18. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
19. Whole genome amplification from a single cell: Implication for genetic analysis
20. Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA
21. Comprehensive human genome amplification using multiple displacement amplification
22. Direct electrophoretic detection of the allelic state of single DNA molecules in human sperm by using the polymerase chain reaction
23. Multiplex genotype determination at a DNA sequence polymorphism cluster in the human immunoglobulin heavy-chain region